ZBIO peer analysis
Zenas BioPharma (ZBIO) against its competitors: price, today's move, 1-year return and market value side by side.
ZBIO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.90 | 8.03% | 59.73% | $559.49M |
| ANNX Annexon | $4.20 | 4.87% | 40.20% | – |
| IMVT Immunovant | $29.10 | 2.50% | 28.26% | $5.86B |
| QTTB Q32 Bio | $9.25 | 4.52% | 286.61% | – |
| TLSA Tiziana Life Sciences | $0.62 | -2.76% | -66.28% | $78.95M |
| TRAX First Tracks Biotherapeutics | $49.00 | 7.86% | – | – |
| UPB Upstream Bio | $3.21 | 0.16% | -86.98% | – |
| ZBIO Zenas BioPharma | $28.26 | 8.99% | -8.65% | – |
- ZBIO's peers: ACRS (Aclaris Therapeutics), ANNX (Annexon), IMVT (Immunovant), QTTB (Q32 Bio), TLSA (Tiziana Life Sciences), TRAX (First Tracks Biotherapeutics), UPB (Upstream Bio).
Updated 2026-11-07 11:56 UTC